(Q42826131)
Statements
Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone (English)
Shigeki Seto
Kyoko Okada
Koichi Kiyota
Shigeki Isogai
Maki Iwago
Takehiro Shinozaki
Yasushi Kohno
Koji Murakami